Showing results (501-510 of 3,564) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|October 13, 2017
Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratioTimothy R Spencer, Keegan J MahoneyJournal of Thrombosis and Thrombolysis|September 17, 2015
Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agentsSunny Patel, Dylan SteenJournal of Thrombosis and Thrombolysis|August 9, 2015
Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillationKonstantinos Tziomalos, Vasilios Giampatzis, Stella D Bouziana, et al.Journal of Thrombosis and Thrombolysis|October 9, 2015
Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary interventionEitan A Friedman, Luisa Texeira, Jessica Delaney, et al.Journal of Thrombosis and Thrombolysis|August 5, 2015
Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparinWouter J Kikkert, Peter M van Brussel, Peter Damman, et al.Journal of Thrombosis and Thrombolysis|July 22, 2017
Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for cliniciansEduardo Vazquez-Garza, Carlos Jerjes-Sanchez, Aline Navarrete, et al.Journal of Thrombosis and Thrombolysis|June 27, 2016
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairmentSeth Woodruff, Guillaume Feugère, Paula Abreu, et al.Journal of Thrombosis and Thrombolysis|September 18, 2015
Heparin: 100 years of pleiotropic effectsAdilson Ferraz PaschoaJournal of Thrombosis and Thrombolysis|December 15, 2015
Bleeding complications in venous thrombosis patients on well-managed warfarinPer Sandén, Henrik Renlund, Peter J Svensson, et al.Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.Pageof 357